Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
10.25
-0.55 (-5.09%)
Oct 20, 2025, 3:59 PM EDT
Telix Pharmaceuticals Employees
Telix Pharmaceuticals had 234 employees as of December 31, 2022. The number of employees increased by 76 or 48.10% compared to the previous year.
Employees
234
Change (1Y)
76
Growth (1Y)
48.10%
Revenue / Employee
$1,570,273
Profits / Employee
$25,637
Market Cap
3.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 234 | 76 | 48.10% |
Dec 31, 2021 | 158 | 149 | 1,655.56% |
Dec 31, 2017 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
American Oncology Network | 1,914 |
Jushi Holdings | 1,234 |
Glass House Brands | 374 |
Silence Therapeutics | 116 |
Elite Pharmaceuticals | 68 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Nuo Therapeutics | 9 |
Telix Pharmaceuticals News
- 4 days ago - TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewsWire
- 5 days ago - Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX - PRNewsWire
- 5 days ago - TELIX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Stockholders - GlobeNewsWire
- 6 days ago - Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance - Benzinga
- 6 days ago - Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance - Benzinga
- 6 days ago - Telix Pharmaceuticals (TLPPF) Raises Revenue Guidance After Strong Q3 - GuruFocus
- 6 days ago - Telix Pharmaceuticals boosts FY25 guidance after strong Q3 - Seeking Alpha
- 6 days ago - Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded - GlobeNewsWire